Compare Huntington Bancshares Incorporated (HBAN) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Huntington Bancshares Incorporated vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Huntington Bancshares Incorporated trades at $15.41 (market cap $31.04B), while Nuvation Bio Inc. Class A Common Stock trades at $5.22 (market cap $1.74B). The key difference: Huntington Bancshares Incorporated is far larger — about 17.8× Nuvation Bio Inc. Class A Common Stock's market cap, and Huntington Bancshares Incorporated pays a 4.04% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Huntington Bancshares Incorporated for 52 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| HBAN | NUVB | |
|---|---|---|
Market Cap | $31.04B | $1.74B |
Volume | 23,864,172 | 9,289,619 |
Sector | Financials | Health |
52-Week High | $19.27 | $9.54 |
52-Week Low | $15.02 | $3.41 |
Typical Hold Time | 52 Days | 0 Days |
Enterprise Value | $49.57B | $1.33B |
Dividend Yield | 4.04% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Huntington Bancshares (HBAN) trades at $15.17, down 1.04% on the day, reflecting recent pressure from margin headwinds and a lowered 2027 earnings outlook. The stock shows a bearish technical signal with moving averages indicating selling pressure, while fundamentals reveal a P/E of 11.67 and net income margin of 24.77%. Recent news highlights increased options activity and a new $0.16 dividend declaration, but investor sentiment is cautious amid interest rate challenges.
HBAN presents a mixed outlook with a consensus price target of $19.60 suggesting 29% upside, supported by shareholder returns via buybacks and dividends. However, risks include persistent net interest margin compression, competitive lending pressures, and macroeconomic sensitivity. The stock's valuation appears reasonable, but earnings misses and guidance cuts warrant close monitoring of upcoming Q3 2026 results for directional clarity.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Huntington Bancshares Incorporated
Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.
Read more on HBAN →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
